Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: Longitudinal microbial and molecular dynamics in the cystic fibrosis lung after Elexacaftor–Tezacaftor–Ivacaftor therapy

Fig. 1

Sampling collection data through time and lung function response to ETI treatment among participants. A Schematic of longitudinal samples collected for this study. Each black line represents a sample collection day. Black arrowheads represent the day in which subjects started on ETI treatment. B Lung function variation for highest ppFEV1% predicted pre- and post-ETI treatment per subject on each group and the absolute delta variation in the change in ppFEV1% predicted per subject post-ETI treatment within each group. The significance was determined through the DM t-test and Welch’s t-test respectively. C Lung function as ppFEV1% predicted of individual subjects through time (days) before and after ETI. Colors represent the treatment status (pre- and post-ETI) in which lung function was recorded and its corresponding significance (T-test) between the two different periods

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us